Congress

• ASGCT's NIH Indirect Funding Sign-On Letter

  March 04, 2025 Congress Research Funding
  Read Statement

• R!A NIH Funding Sign On

  February 25, 2025 Congress Clinical Development , Congress , Research Funding
  Read Statement

• SCD Comprehensive Care Act Sign On

  November 14, 2024 Congress
  Read Statement

• RFI: Securing and Enhancing Biomedical Supply Chains

  October 04, 2024 Congress Regulatory Policy , CMC
  Read Statement

• Request for Information from Stakeholders on the Enacted Cures 2.0 Act

  August 02, 2024 Congress Regulatory Policy , Clinical Development , Research Funding , New Technologies
  Read Statement

• Sickle Cell Disease Comprehensive Care Act Sign On

  June 06, 2024 Congress Congress
  Read Statement

• Written Testimony: Legislative Proposals to Support Patients with Rare Diseases

  March 19, 2024 Congress Clinical Development , Research Funding , New Technologies
  Read Statement

• RFI Employee Retirement Income Security Act (ERISA)

  March 15, 2024 Congress Payment Policy
  Read Statement

• RFI: Improving Americans’ Access to Gene Therapies

  January 22, 2024 Congress Regulatory Policy , Clinical Development , Payment Policy
  Read Statement

• ASAE Power of Associations Sign On

  March 27, 2023 Congress Congress
  Read Statement

• FY23 Appropriations Omnibus

  December 06, 2022 Congress Congress , Research Funding
  Read Statement

• Sickle Cell Disease Comprehensive Care Act

  November 17, 2022 Congress Congress
  Read Statement

• Diversity Plans to Improve Enrollment of Participants from Underrepresented Populations in Clinical Trials Guidance

  June 13, 2022 Congress Regulatory Policy , Clinical Development , Bioethics , FDA Guidance
  Read Statement

• PDUFA VII Reauthorization

  February 11, 2022 Congress Regulatory Policy , Clinical Development , CMC , Congress
  Read Statement

• Prevent Pandemics Act Discussion Draft

  February 04, 2022 Congress Regulatory Policy , CMC , Congress , Research Funding
  Read Statement

• 21st Century Cures 2.0 [Introduced]

  December 30, 2021 Congress Regulatory Policy , Clinical Development , CMC , Bioethics , Congress , Research Funding , NBS
  Read Statement

  1 2 3